Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 71610-659

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 71610-659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 20 mg (71610 0659 09)

Label for Pantoprazole Sodium DR, USP 20 mg delayed-release tablets, packaged as 9000 tablets. The manufacturer is Evaric Pharmaceuticals Inc., Hauppauge, NY, and repackaging is done by Aphena Pharma, Cookeville, TN. The label includes storage instructions and batch information.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Structure.jpg (Structure)

Chemical structure of the active ingredient pantoprazole, shown with its molecular components including fluorine atoms and water of hydration (1.5 H2O). The structure depicts the molecular formula relevant to the pantoprazole sodium product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.